Location: New York, NY
CIK: 0001854423 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 13, 2025
Total Value: $103M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 115,245 | $64.47M | 62.4% | $586.08 | — | TR UNIT | 78462F103 |
| EFA | ISHARES TR | 466,000 | $38.09M | 36.9% | $75.61 | — | MSCI EAFE ETF | 464287465 |
| LFCR | LIFECORE BIOMEDICAL INC | 19,700 | $139K | 0.1% | $6.39 | -2.7% | COM | 514766104 |
| — | XYLO TECHNOLOGIES LTD | 26,059 | $128K | 0.1% | $3.62 | — | SPONSORED ADS | 58471G508 |
| WETH | WETOUCH TECHNOLOGY INC | 67,954 | $98,533 | 0.1% | $1.77 | -14.1% | COM NEW | 961881208 |
| CLAR | CLARUS CORP NEW | 22,200 | $83,250 | 0.1% | $4.35 | +0.3% | COM | 18270P109 |
| — | PRESIDIO PPTY TR INC | 134,125 | $77,122 | 0.1% | $0.80 | — | COM CL A | 74102L303 |
| — | ENZO BIOCHEM INC | 156,303 | $57,832 | 0.1% | $0.64 | — | COM | 294100102 |
| — | ESSA PHARMA INC | 31,700 | $50,086 | 0.0% | $1.78 | — | COM NEW | 29668H708 |
| ANTX | AN2 THERAPEUTICS INC | 23,234 | $31,598 | 0.0% | $1.26 | 0.0% | COM | 037326105 |
| — | LAVA THERAPEUTICS NV | 23,000 | $29,210 | 0.0% | $1.27 | — | SHS | N51517105 |
| BRN | BARNWELL INDS INC | 15,000 | $24,300 | 0.0% | $1.82 | -8.3% | COM | 068221100 |
| DSWL | DESWELL INDS INC | 10,000 | $23,550 | 0.0% | $2.35 | -5.4% | COM | 250639101 |
| LGL/WS | LGL GROUP INC | 26,200 | $8,381 | 0.0% | $0.15 | — | *W EXP 11/16/202 | 50186A132 |